Health Sciences News

UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.

{hide_init_page_description}

yes

The Latest

Rebecsinib Clinical Trial Means New Options for Blood Cancer

A clinical trial of rebecsinib — an investigational drug that inhibits the ADAR1 gene involved in the growth of more than 20 cancers — is underway at UC San Diego.

Mindfulness-Based Therapy for Opioid Misuse Offers Massive Return on Investment

A mindfulness-based treatment for opioid use disorder could generate $12 in economic benefit for every dollar spent, a massive improvement on current approaches.

One Month on a Vegan Diet Shifts Epigenetic Patterns Associated with Aging and Inflammation

Researchers from University of California San Diego have found that switching to a vegan diet for just one month can alter the body’s epigenetic landscape in ways associated with reduced inflammation and biological aging.

From Code to Care: How UC San Diego Is Leading the Way in AI for Health Care

At the U.S. News & World Report Healthcare of Tomorrow conference, leaders from UC San Diego and from across the health care industry gathered in Washington, D.C., to explore a defining question: How can artificial intelligence improve health care while keeping patients at the center?

Gene Regulation Map Reveals Treatment Targets for Heart Failure

Researchers from University of California San Diego have created the most detailed map to date of how gene regulation breaks down in human heart failure, revealing how different cardiac cell types drive disease and pointing to potential new therapeutic targets.

Adolescent Substance Use Continues to Rise Through Mid-Teens, National Study Finds

Researchers from UC San Diego analyzed the latest data from one of the nation’s largest long-term studies of youth to better understand when substance use begins, how it changes during adolescence and which substances are most commonly used together.